Avai Bio (AVAI) EBITDA Margin (2019 - 2020)

Avai Bio's (AVAI) quarterly EBITDA Margin came in at 278.81% in Q4 2020, up 2830.63% quarter-over-quarter from 10.21% in Q3 2020.

Avai Bio (AVAI) EBITDA Margin (2019 - 2020) Analysis & Trends

Avai Bio has disclosed EBITDA Margin across 2 years of filings, most recently posting 278.81% for Q4 2020.

  • EBITDA Margin for Q4 2020 came in at 278.81%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was 1.77% (up 100145.0% YoY), and the FY2023 annual result was 127.35%, changed N/A from the prior year.
  • EBITDA Margin came in at 278.81% for Q4 2020 at Avai Bio, up from 10.21% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 278.81% in Q4 2020 to a low of 208.85% in Q2 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Sap Se 262.33 Bn 244.36 Bn 8.16 Bn 28.69%
2 Full Truck Alliance 173.49 Bn 170.93 Bn - -
3 Salesforce 158.80 Bn 146.96 Bn 8.56 Bn 21.08%
4 Shopify 144.36 Bn 138.62 Bn 1.55 Bn -18.49%
5 Uber Technologies 144.25 Bn 143.21 Bn 11.88 Bn 14.56%
6 ServiceNow 118.74 Bn 113.56 Bn 2.83 Bn 12.12%
7 Cadence Design Systems 107.33 Bn 105.92 Bn 1.26 Bn 29.26%
8 Adobe 100.50 Bn 93.61 Bn 5.73 Bn 37.79%
9 Automatic Data Processing 92.49 Bn 89.26 Bn 2.87 Bn -22.99%
10 Avai Bio - - - -

Historic Data

Download Data
DateValue
Dec 31, 2020 278.81%
Sep 30, 2020 -10.21%
Jun 30, 2020 20.14%
Mar 31, 2020 -67.81%
Jun 30, 2019 -208.85%